Terms: = Prostate cancer AND CARS, P49589, 833, ENSG00000110619 AND Prognosis
8 results:
1. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting prognosis.
Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
[TBL] [Abstract] [Full Text] [Related]
2. Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0-25.0 ng ml
Gao XD; Miao Q; Zhang JL; Zhai JZ; Gui XM; Cai YH; Niu Q; Cai B
Asian J Androl; 2022; 24(2):195-200. PubMed ID: 34916475
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events.
Zeng KL; Sahgal A; Tseng CL; Myrehaug S; Soliman H; Detsky J; Atenafu EG; Lee Y; Campbell M; Maralani P; Husain ZA
Neurosurgery; 2021 Apr; 88(5):971-979. PubMed ID: 33475723
[TBL] [Abstract] [Full Text] [Related]
4. C-reactive Protein Is a Predictor of prognosis of prostate cancer: A Systematic Review and Meta-Analysis.
Liao DW; Hu X; Wang Y; Yang ZQ; Li X
Ann Clin Lab Sci; 2020 Mar; 50(2):161-171. PubMed ID: 32366552
[TBL] [Abstract] [Full Text] [Related]
5. Validating the European randomised study for screening of prostate cancer (ERSPC) risk calculator in a contemporary South African cohort.
Kowlessur B; Phull M; Patel B; Henry M; Lazarus J
World J Urol; 2020 Jul; 38(7):1711-1718. PubMed ID: 31522234
[TBL] [Abstract] [Full Text] [Related]
6. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
[TBL] [Abstract] [Full Text] [Related]
7. The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.
Pan X; Zhang X; Gong J; Tan J; Yin X; Tang Q; Shu K; Shen P; Zeng H; Chen N
Prostate; 2016 Jun; 76(9):823-33. PubMed ID: 27159572
[TBL] [Abstract] [Full Text] [Related]
8. Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy.
Mitra R; Chao O; Urasaki Y; Goodman OB; Le TT
BMC Cancer; 2012 Nov; 12():540. PubMed ID: 23171028
[TBL] [Abstract] [Full Text] [Related]